The newest cancer drugs cost over $100,000 for a year of treatment. There are fairer ways to set prices.
Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system.
Biotech startup Greenlight Biosciences has a cell-free approach to microbial chemical production.
Study suggests how brain technology could one day tap into thoughts.
Scientists use immune cells to smuggle molecules across the blood-brain barrier in the hopes of treating neurodegenerative diseases.
World’s largest smartphone chipmaker offers to custom-build very efficient neuro-inspired chips for phones, robots, and vision systems.
Neuroscientists Daniela Schiller says every time you recall a memory, it changes, and that can be a useful thing.
Bioethicists are outraged by 23andMe's patent on predicting traits in children. Should you be too?
Several gene therapies are or will soon be in late-stage human trials. One of them could be the first to get FDA approval for sale in the U.S.
An upcoming film, The Perfect 46, is about a fictional genomics company with a not-so-fictional idea.